Delcath Systems, Inc.
Delcath Systems, Inc. (DCTH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DCTH · as of Jun 8, 2026
Key Statistics
Explore Delcath Systems, Inc. Data
dcth stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 72.7%
The DCTH analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $23.00, representing +110.24% upside from the current price of $10.94.
Competitors & Peers
dcth competitorsDCTH
AGL
BWAY
CERS
MASS
NAKAStock Performance
Full HistoryAbout Delcath Systems, Inc.
Delcath Systems, Inc. is an interventional oncology firm operating in the United States and Europe, dedicated to developing treatments for both primary and secondary liver cancers. Its leading investi…
what is delcath systems, inc. · dcth stock overview · delcath systems, inc. company profile · who is delcath systems, inc. ceo · dcth NASDAQ · delcath systems, inc. headquarters · delcath systems, inc. business segments
About Stock Overview & Key Data
Delcath Systems, Inc. (DCTH) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since May 3, 2018. As of the latest trading session, DCTH stock price is $10.94, with a market capitalization of $377.7M. The stock has returned -31.43% over the past 12 months and +8.28% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Delcath Systems, Inc. stock is Buy, with an average 12-month price target of $23.00. In fiscal year 2025, Delcath Systems, Inc. reported revenue of $85.2M and net income of $2.7M. For detailed data — including Delcath Systems, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Delcath Systems, Inc. (DCTH) stock price is $10.94. The stock is traded on NASDAQ under the ticker symbol DCTH. The 52-week range is $8.12 – $17.35.